Search
Cyclomethicone 5
go.drugbank.com/drugs/DB11244ApprovedCyclomethicone 5 is member of cyclomethicone, which are a group of liquid methyl siloxanes that have low viscosity and high volatility. Cyclomethicones are cyclic in structure with a monomer backbone of one silicon and two oxygen atoms b...
Mixtures: Secret Key Tattoo Cover Cushion Spf50 Plus (23 Natural Beige), Secret Key Tattoo Cover Cushion Spf50 Plus (21 Light Beige)Ephedrine
go.drugbank.com/drugs/DB01364ApprovedInvestigational[A193701,A193704,L12975] Ephedrine was granted a type 7 FDA Approval on 29 April 2016.[L12975]
Mixtures: COPHADYL-E COUGH LINCTUS, FLUKOL X-TRAGefapixant
go.drugbank.com/drugs/DB15097Approved[L48596,L48591] It is the first therapy to be approved for the treatment of RCC or UCC in the EU.[L48601] … It received approval in both Japan and Switzerland in 2022 for the treatment of adult patients with RCC and UCC, and received subsequent approval in the EU in September 2023 for the same indications.
TOL2
go.drugbank.com/drugs/DB17918ExperimentalTOL2 is a modified form of the acetylcholine receptor being investigated for the treatment of myasthenia gravis.[A260117]
Trimetazidine
go.drugbank.com/drugs/DB09069ApprovedInvestigational[A233215] Trimetazidine is not FDA approved. However, it has been approved in France since 1978.[L33020]
Enasidenib
go.drugbank.com/drugs/DB13874ApprovedInvestigationalEnasidenib is an orally available treatment for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with specific mutations in the isocitrate dehydrogenase 2 (IDH2) gene, which is a recurrent mutation...
Cyclopentamine
go.drugbank.com/drugs/DB08999ApprovedWithdrawnCyclopentamine was an over the counter treatment for nasal congestion in Europe and Australia.
Phenyl trimethicone
go.drugbank.com/drugs/DB11313ApprovedMixtures: Secret Key Tattoo Cover Cushion Spf50 Plus (23 Natural Beige), Secret Key Tattoo Cover Cushion Spf50 Plus (21 Light Beige)Grazoprevir
go.drugbank.com/drugs/DB11575ApprovedThese enzymes are essential for viral replication and serve to cleave the virally encoded polyprotein into mature proteins like NS3, NS4A, NS4B, NS5A and NS5B [FDA Label]. … in the NS5A protein and previous treatment failure with [DB00811], [DB00008], [DB00022], or other NS3/4A inhibitors like [DB08873], [DB06290], or [DB05521] [FDA Label].